NASDAQ:LMNS

Lumenis Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.

Add

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive LMNS News and Ratings via Email

Sign-up to receive the latest news and ratings for Lumenis and its competitors with MarketBeat's FREE daily newsletter.

About Lumenis

Lumenis Ltd. (Lumenis) is a provider of energy-based, minimally invasive clinical solutions. The Company operates through three segments: surgical, ophthalmic and aesthetic. The Company offers energy-based solutions for medically necessary and elective procedures, primarily for the aging population. Its solutions include the holmium laser, the Lumenis Pulse 120H, used for urologic applications; the VersaPulse PowerSuite platform which uses holmium lasers for urologic applications; the M22 multi-energy, a multi-application platform for the treatment of various skin conditions, and the Selecta multi-modality platform for retinal, secondary cataract and glaucoma therapies. It offers products to hospitals, outpatient clinics, ambulatory surgery centers, physicians' offices, private clinics and aesthetic chains. Its locations include Yokneam, Israel, where surgical and aesthetic products are manufactured, and Salt Lake City, Utah, where ophthalmic products are manufactured.

Acne Spot Treatment Devices Market: Beating Growth Expectations- Lumenis, Conair, Pulsaderm, Johnson & Johnson
March 3, 2020 | www.marketwatch.com

Lumenis (LMNS) Stock Jumping on Acquisition Announcement
September 25, 2019 | www.thestreet.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: N/A
Sub-Industry: N/A
Sector: N/A
Current Symbol: NASDAQ:LMNS
Previous Symbol
CUSIP: N/A
CIK: 1004945
Web: www.lumenis.com
Phone: +972-4-9599000
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Market Cap: N/A
Next Earnings Date: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.88 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Lumenis.

4.4 Community Rank

Outperform Votes
Lumenis has received 86 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Lumenis has received 46 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Lumenis has received 65.15% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Lumenis and other stocks. Vote “Outperform” if you believe LMNS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LMNS will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Lumenis does not currently pay a dividend.
Dividend Growth
Lumenis does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Lumenis insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Lumenis (NASDAQ:LMNS) Frequently Asked Questions

What stocks does MarketBeat like better than Lumenis?: Wall Street analysts have given Lumenis a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Lumenis wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
How were Lumenis' earnings last quarter?: Lumenis Ltd. (NASDAQ:LMNS) issued its quarterly earnings data on Tuesday, May, 12th. The medical equipment provider reported $0.06 EPS for the quarter, missing the Zacks' consensus estimate of $0.11 by $0.05. The medical equipment provider earned $68.51 million during the quarter, compared to analyst estimates of $68.36 million. The business's revenue was up 4.1% compared to the same quarter last year. During the same quarter last year, the company posted $0.07 earnings per share.
View Lumenis' earnings history.
Who are Lumenis' key executives?: Lumenis' management team includes the following people:
Harel Beit-On, Chairman of the Board (Age 52)
Zipora Ozer-Armon, Chief Executive Officer (Age 51)
Ophir Yakovian, Chief Financial Officer
Qiying Zhai, Senior Vice President and Regional President, Lumenis China
Eran Cohen, Vice President - Global Operations (Age 57)
Elad Benjamin, Vice President and General Manager - Surgical Strategic Business Unit
Hadas Padan, Vice President and General Manager Vision Strategic Business Unit
Roy Ramati, Vice President, General Manager - Aesthetic Strategic Business Unit
Kfir Azoulay, Vice President - Corporate Marketing
Ido Ben-Tov, Vice President - Service
What other stocks do shareholders of Lumenis own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Lumenis investors own include Supernus Pharmaceuticals (SUPN), Aralez Pharmaceuticals (ARLZ), Omeros (OMER), Performant Financial (PFMT), Wright Medical Group (WMGI), Biocept (BIOC), Bausch Health Companies (BHC), Bioanalytical Systems (BASI), Avadel Pharmaceuticals (AVDL) and Aptevo Therapeutics (APVO).
What is Lumenis' stock symbol?: Lumenis trades on the NASDAQ under the ticker symbol "LMNS."
What is Lumenis' official website?: The official website for Lumenis is www.lumenis.com.
Where are Lumenis' headquarters?: Lumenis is headquartered at Hakidma 6 Yokneam Industrial Park P.O.B. # 240, YOKNEAM, 2069204, Israel.
How can I contact Lumenis?: Lumenis' mailing address is Hakidma 6 Yokneam Industrial Park P.O.B. # 240, YOKNEAM, 2069204, Israel. The medical equipment provider can be reached via phone at +972-4-9599000.

This page was last updated on 10/26/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.